Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OneMedNet (ONMD) Cash from Operations (2022 - 2025)

OneMedNet has reported Cash from Operations over the past 4 years, most recently at 1713000.0 for Q4 2025.

  • Quarterly Cash from Operations rose 14.18% to 1713000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 7503000.0 through Dec 2025, down 7.93% year-over-year, with the annual reading at 7503000.0 for FY2025, 7.93% down from the prior year.
  • Cash from Operations was 1713000.0 for Q4 2025 at OneMedNet, down from 1558000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 151653.0 in Q2 2022 and troughed at 3906463.0 in Q4 2022.
  • The 4-year median for Cash from Operations is 1552500.0 (2024), against an average of 1496812.5.
  • The largest YoY upside for Cash from Operations was 55.84% in 2023 against a maximum downside of 535.66% in 2023.
  • A 4-year view of Cash from Operations shows it stood at 3906463.0 in 2022, then skyrocketed by 55.84% to 1725000.0 in 2023, then fell by 15.71% to 1996000.0 in 2024, then rose by 14.18% to 1713000.0 in 2025.
  • Per Business Quant, the three most recent readings for ONMD's Cash from Operations are 1713000.0 (Q4 2025), 1558000.0 (Q3 2025), and 2284000.0 (Q2 2025).